Journal Cover The Lancet
  [SJR: 14.638]   [H-I: 600]   [2052 followers]  Follow
    
   Full-text available via subscription Subscription journal
   ISSN (Print) 0140-6736 - ISSN (Online) 1474-547X
   Published by Elsevier Homepage  [3042 journals]
  • Guided graded exercise self-help as a treatment of fatigue in chronic
           fatigue syndrome
    • Authors: Daniel J Clauw
      Pages: 335 - 336
      Abstract: Publication date: 22–28 July 2017
      Source:The Lancet, Volume 390, Issue 10092
      Author(s): Daniel J Clauw


      PubDate: 2017-07-24T04:30:16Z
      DOI: 10.1016/s0140-6736(17)30577-9
       
  • Informing health choices in low-resource settings
    • Authors: Laura Gauer Bermudez; Stephanie A Grilo; John S Santelli; Fred M Ssewamala
      Pages: 336 - 338
      Abstract: Publication date: 22–28 July 2017
      Source:The Lancet, Volume 390, Issue 10092
      Author(s): Laura Gauer Bermudez, Stephanie A Grilo, John S Santelli, Fred M Ssewamala


      PubDate: 2017-07-24T04:30:16Z
      DOI: 10.1016/s0140-6736(17)31290-4
       
  • Saving lives with equity—the efficient route to the SDGs
    • Authors: Kevin Watkins
      Pages: 339 - 340
      Abstract: Publication date: 22–28 July 2017
      Source:The Lancet, Volume 390, Issue 10092
      Author(s): Kevin Watkins


      PubDate: 2017-07-24T04:30:16Z
      DOI: 10.1016/s0140-6736(17)31873-1
       
  • 90-90-90 and ending AIDS: necessary and feasible
    • Authors: Reuben Granich; Brian Williams; Julio Montaner; José M Zuniga
      Pages: 341 - 343
      Abstract: Publication date: 22–28 July 2017
      Source:The Lancet, Volume 390, Issue 10092
      Author(s): Reuben Granich, Brian Williams, Julio Montaner, José M Zuniga


      PubDate: 2017-07-24T04:30:16Z
      DOI: 10.1016/s0140-6736(17)31872-x
       
  • The International AIDS Society—Lancet Commission on the future of the
           HIV response and global health
    • Authors: Chris Beyrer; Pamela Das; Richard Horton; Owen Ryan; Linda-Gail Bekker
      Pages: 344 - 345
      Abstract: Publication date: 22–28 July 2017
      Source:The Lancet, Volume 390, Issue 10092
      Author(s): Chris Beyrer, Pamela Das, Richard Horton, Owen Ryan, Linda-Gail Bekker


      PubDate: 2017-07-24T04:30:16Z
      DOI: 10.1016/s0140-6736(17)31874-3
       
  • The HIV response in Ukraine: at a crossroads
    • Authors: Andrew Green
      Pages: 347 - 348
      Abstract: Publication date: 22–28 July 2017
      Source:The Lancet, Volume 390, Issue 10092
      Author(s): Andrew Green


      PubDate: 2017-07-24T04:30:16Z
      DOI: 10.1016/s0140-6736(17)31915-3
       
  • The UN adopts treaty to ban the use of nuclear weapons
    • Authors: John Zarocostas
      First page: 349
      Abstract: Publication date: 22–28 July 2017
      Source:The Lancet, Volume 390, Issue 10092
      Author(s): John Zarocostas


      PubDate: 2017-07-24T04:30:16Z
      DOI: 10.1016/s0140-6736(17)31870-6
       
  • Public health commissioner appointed to lead US CDC
    • Authors: Rita Rubin
      First page: 350
      Abstract: Publication date: 22–28 July 2017
      Source:The Lancet, Volume 390, Issue 10092
      Author(s): Rita Rubin


      PubDate: 2017-07-24T04:30:16Z
      DOI: 10.1016/s0140-6736(17)31916-5
       
  • Tuberculosis
    • Authors: Richard Barnett
      First page: 351
      Abstract: Publication date: 22–28 July 2017
      Source:The Lancet, Volume 390, Issue 10092
      Author(s): Richard Barnett


      PubDate: 2017-07-24T04:30:16Z
      DOI: 10.1016/s0140-6736(17)31876-7
       
  • Putting LGBTQ people back on the canvas of history
    • Authors: Owen Jones
      Pages: 352 - 353
      Abstract: Publication date: 22–28 July 2017
      Source:The Lancet, Volume 390, Issue 10092
      Author(s): Owen Jones


      PubDate: 2017-07-24T04:30:16Z
      DOI: 10.1016/s0140-6736(17)31877-9
       
  • Taking a dose of Roald Dahl's marvellous medicine
    • Authors: Peter Ranscombe
      Pages: 354 - 355
      Abstract: Publication date: 22–28 July 2017
      Source:The Lancet, Volume 390, Issue 10092
      Author(s): Peter Ranscombe


      PubDate: 2017-07-24T04:30:16Z
      DOI: 10.1016/s0140-6736(17)31879-2
       
  • Magic and loss
    • Authors: Stephen Ginn
      First page: 355
      Abstract: Publication date: 22–28 July 2017
      Source:The Lancet, Volume 390, Issue 10092
      Author(s): Stephen Ginn


      PubDate: 2017-07-24T04:30:16Z
      DOI: 10.1016/s0140-6736(17)31878-0
       
  • Simone Veil
    • Authors: Barbara Casassus
      First page: 356
      Abstract: Publication date: 22–28 July 2017
      Source:The Lancet, Volume 390, Issue 10092
      Author(s): Barbara Casassus


      PubDate: 2017-07-24T04:30:16Z
      DOI: 10.1016/s0140-6736(17)31880-9
       
  • Ending AIDS: myth or reality'
    • Authors: Brian G Williams; Reuben Granich
      First page: 357
      Abstract: Publication date: 22–28 July 2017
      Source:The Lancet, Volume 390, Issue 10092
      Author(s): Brian G Williams, Reuben Granich


      PubDate: 2017-07-24T04:30:16Z
      DOI: 10.1016/s0140-6736(17)31832-9
       
  • Nelly Mugo and the response to HIV: more than just PrEP advocacy
    • Authors: Nathan Hodson; Susan Bewley
      First page: 358
      Abstract: Publication date: 22–28 July 2017
      Source:The Lancet, Volume 390, Issue 10092
      Author(s): Nathan Hodson, Susan Bewley


      PubDate: 2017-07-24T04:30:16Z
      DOI: 10.1016/s0140-6736(17)31625-2
       
  • The sun is shining on Cyprus's National Health Service
    • Authors: George Samoutis; Constantinos Paschalides
      First page: 360
      Abstract: Publication date: 22–28 July 2017
      Source:The Lancet, Volume 390, Issue 10092
      Author(s): George Samoutis, Constantinos Paschalides


      PubDate: 2017-07-24T04:30:16Z
      DOI: 10.1016/s0140-6736(17)31826-3
       
  • NHS manifesto: the missing piece of the puzzle
    • Authors: Ellen Stewart; Ingrid Young; Sarah Cunningham-Burley
      First page: 361
      Abstract: Publication date: 22–28 July 2017
      Source:The Lancet, Volume 390, Issue 10092
      Author(s): Ellen Stewart, Ingrid Young, Sarah Cunningham-Burley


      PubDate: 2017-07-24T04:30:16Z
      DOI: 10.1016/s0140-6736(17)31446-0
       
  • NHS manifesto: the missing piece of the puzzle – Authors' reply
    • Authors: David Stuckler; Nigel Crisp
      First page: 361
      Abstract: Publication date: 22–28 July 2017
      Source:The Lancet, Volume 390, Issue 10092
      Author(s): David Stuckler, Nigel Crisp


      PubDate: 2017-07-24T04:30:16Z
      DOI: 10.1016/s0140-6736(17)31439-3
       
  • Diagnostic accuracy of the PROMIS study
    • Authors: Simpa S Salami; Arvin K George; Jeffrey S Montgomery; Todd M Morgan; Ganesh S Palapattu
      First page: 362
      Abstract: Publication date: 22–28 July 2017
      Source:The Lancet, Volume 390, Issue 10092
      Author(s): Simpa S Salami, Arvin K George, Jeffrey S Montgomery, Todd M Morgan, Ganesh S Palapattu


      PubDate: 2017-07-24T04:30:16Z
      DOI: 10.1016/s0140-6736(17)31598-2
       
  • Diagnostic accuracy of the PROMIS study – Authors’ reply
    • Authors: Hashim U Ahmed; Louise C Brown; Richard Kaplan; Chris Parker; Mark Emberton
      First page: 362
      Abstract: Publication date: 22–28 July 2017
      Source:The Lancet, Volume 390, Issue 10092
      Author(s): Hashim U Ahmed, Louise C Brown, Richard Kaplan, Chris Parker, Mark Emberton


      PubDate: 2017-07-24T04:30:16Z
      DOI: 10.1016/s0140-6736(17)31595-7
       
  • Synchronous distal phalangeal metastases from primary non-small-cell lung
           cancer
    • Authors: Richard J Ross; Nigel C Mann
      First page: 399
      Abstract: Publication date: 22–28 July 2017
      Source:The Lancet, Volume 390, Issue 10092
      Author(s): Richard J Ross, Nigel C Mann


      PubDate: 2017-07-24T04:30:16Z
      DOI: 10.1016/s0140-6736(17)31288-6
       
  • Dilated cardiomyopathy
    • Authors: Robert G Weintraub; Christopher Semsarian; Peter Macdonald
      Pages: 400 - 414
      Abstract: Publication date: 22–28 July 2017
      Source:The Lancet, Volume 390, Issue 10092
      Author(s): Robert G Weintraub, Christopher Semsarian, Peter Macdonald
      Dilated cardiomyopathy is defined by the presence of left ventricular dilatation and contractile dysfunction. Genetic mutations involving genes that encode cytoskeletal, sarcomere, and nuclear envelope proteins, among others, account for up to 35% of cases. Acquired causes include myocarditis and exposure to alcohol, drugs and toxins, and metabolic and endocrine disturbances. The most common presenting symptoms relate to congestive heart failure, but can also include circulatory collapse, arrhythmias, and thromboembolic events. Secondary neurohormonal changes contribute to reverse remodelling and ongoing myocyte damage. The prognosis is worst for individuals with the lowest ejection fractions or severe diastolic dysfunction. Treatment of chronic heart failure comprises medications that improve survival and reduce hospital admission—namely, angiotensin converting enzyme inhibitors and β blockers. Other interventions include enrolment in a multidisciplinary heart failure service, and device therapy for arrhythmia management and sudden death prevention. Patients who are refractory to medical therapy might benefit from mechanical circulatory support and heart transplantation. Treatment of preclinical disease and the potential role of stem-cell therapy are being investigated.

      PubDate: 2017-07-24T04:30:16Z
      DOI: 10.1016/s0140-6736(16)31713-5
       
  • Progress in evidence-based medicine: a quarter century on
    • Authors: Benjamin Djulbegovic; Gordon H Guyatt
      Pages: 415 - 423
      Abstract: Publication date: 22–28 July 2017
      Source:The Lancet, Volume 390, Issue 10092
      Author(s): Benjamin Djulbegovic, Gordon H Guyatt
      In response to limitations in the understanding and use of published evidence, evidence-based medicine (EBM) began as a movement in the early 1990s. EBM's initial focus was on educating clinicians in the understanding and use of published literature to optimise clinical care, including the science of systematic reviews. EBM progressed to recognise limitations of evidence alone, and has increasingly stressed the need to combine critical appraisal of the evidence with patient's values and preferences through shared decision making. In another progress, EBM incorporated and further developed the science of producing trustworthy clinical practice guidelines pioneered by investigators in the 1980s. EBM's enduring contributions to clinical medicine include placing the practice of medicine on a solid scientific basis, the development of more sophisticated hierarchies of evidence, the recognition of the crucial role of patient values and preferences in clinical decision making, and the development of the methodology for generating trustworthy recommendations.

      PubDate: 2017-07-24T04:30:16Z
      DOI: 10.1016/s0140-6736(16)31592-6
       
  • A developmental approach to the prevention of hypertension and kidney
           disease: a report from the Low Birth Weight and Nephron Number Working
           Group
    • Authors: Valerie A Luyckx; Norberto Perico; Marco Somaschini; Dario Manfellotto; Herbert Valensise; Irene Cetin; Umberto Simeoni; Karel Allegaert; Bjorn Egil Vikse; Eric A Steegers; Dwomoa Adu; Giovanni Montini; Giuseppe Remuzzi; Barry M Brenner; Dwomoa Adu; Karel Allegaert; Chiara Benedetto; Barry M. Brenner; Irene Cetin; Jennifer Charlton; Robert Chevalier; Monica Cortinovis; Rosario D'Anna; Johannes Duvekot; Joaquin Escribano; Vassilios Fanos; Enrico Ferrazzi; Tiziana Frusca; Richard Glassock; Wilfried Gyselaers; Valerie Luyckx; Dario Manfellotto; Federico Mecacci; Giovanni Montini; Clive Osmond; Norberto Perico; Luca Ramenghi; Giuseppe Remuzzi; Paola Romagnani; Antonio Santoro; Umberto Simeoni; Marco Somaschini; Eric A. Steegers; Herbert Valensise; Bjorn Egil Vikse
      Pages: 424 - 428
      Abstract: Publication date: 22–28 July 2017
      Source:The Lancet, Volume 390, Issue 10092
      Author(s): Valerie A Luyckx, Norberto Perico, Marco Somaschini, Dario Manfellotto, Herbert Valensise, Irene Cetin, Umberto Simeoni, Karel Allegaert, Bjorn Egil Vikse, Eric A Steegers, Dwomoa Adu, Giovanni Montini, Giuseppe Remuzzi, Barry M Brenner


      PubDate: 2017-07-24T04:30:16Z
      DOI: 10.1016/s0140-6736(17)30576-7
       
  • Account for primary health care when indexing access and quality
    • Authors: Felicity Goodyear-Smith; Chris van Weel
      Pages: 205 - 206
      Abstract: Publication date: 15–21 July 2017
      Source:The Lancet, Volume 390, Issue 10091
      Author(s): Felicity Goodyear-Smith, Chris van Weel


      PubDate: 2017-07-24T04:30:16Z
      DOI: 10.1016/s0140-6736(17)31289-8
       
  • Ketamine fails to prevent postoperative delirium
    • Authors: James C Eisenach
      Pages: 206 - 208
      Abstract: Publication date: 15–21 July 2017
      Source:The Lancet, Volume 390, Issue 10091
      Author(s): James C Eisenach


      PubDate: 2017-07-24T04:30:16Z
      DOI: 10.1016/s0140-6736(17)31504-0
       
  • The global HIV/AIDS epidemic—progress and challenges
    • Authors: Lancet
      Abstract: Publication date: 22–28 July 2017
      Source:The Lancet, Volume 390, Issue 10092
      Author(s): The Lancet


      PubDate: 2017-07-24T04:30:16Z
       
  • Medical education reform in China
    • Authors: Lancet
      Abstract: Publication date: 22–28 July 2017
      Source:The Lancet, Volume 390, Issue 10092
      Author(s): The Lancet


      PubDate: 2017-07-24T04:30:16Z
       
  • Growing concerns of hepatitis E in Europe
    • Authors: Lancet
      Abstract: Publication date: 22–28 July 2017
      Source:The Lancet, Volume 390, Issue 10092
      Author(s): The Lancet


      PubDate: 2017-07-24T04:30:16Z
       
  • Offline: NCDs—why are we failing'
    • Authors: Richard Horton
      Abstract: Publication date: 22–28 July 2017
      Source:The Lancet, Volume 390, Issue 10092
      Author(s): Richard Horton


      PubDate: 2017-07-24T04:30:16Z
       
  • Progress on dementia—leaving no one behind
    • Authors: Martin Prince
      Abstract: Publication date: Available online 20 July 2017
      Source:The Lancet
      Author(s): Martin Prince


      PubDate: 2017-07-24T04:30:16Z
      DOI: 10.1016/s0140-6736(17)31757-9
       
  • Dementia prevention, intervention, and care
    • Authors: Gill Livingston; Andrew Sommerlad; Vasiliki Orgeta; Sergi G Costafreda; Jonathan Huntley; David Ames; Clive Ballard; Sube Banerjee; Alistair Burns; Jiska Cohen-Mansfield; Claudia Cooper; Nick Fox; Laura N Gitlin; Robert Howard; Helen C Kales; Eric B Larson; Karen Ritchie; Kenneth Rockwood; Elizabeth L Sampson; Quincy Samus; Lon S Schneider; Geir Selbæk; Linda Teri; Naaheed Mukadam
      Abstract: Publication date: Available online 20 July 2017
      Source:The Lancet
      Author(s): Gill Livingston, Andrew Sommerlad, Vasiliki Orgeta, Sergi G Costafreda, Jonathan Huntley, David Ames, Clive Ballard, Sube Banerjee, Alistair Burns, Jiska Cohen-Mansfield, Claudia Cooper, Nick Fox, Laura N Gitlin, Robert Howard, Helen C Kales, Eric B Larson, Karen Ritchie, Kenneth Rockwood, Elizabeth L Sampson, Quincy Samus, Lon S Schneider, Geir Selbæk, Linda Teri, Naaheed Mukadam


      PubDate: 2017-07-24T04:30:16Z
      DOI: 10.1016/s0140-6736(17)31363-6
       
  • Gill Livingston: transforming dementia prevention and care
    • Authors: Rachael Davies
      Abstract: Publication date: Available online 20 July 2017
      Source:The Lancet
      Author(s): Rachael Davies


      PubDate: 2017-07-24T04:30:16Z
      DOI: 10.1016/s0140-6736(17)31913-x
       
  • Prevention and management of dementia: a priority for public health
    • Authors: Helen Frankish; Richard Horton
      Abstract: Publication date: Available online 20 July 2017
      Source:The Lancet
      Author(s): Helen Frankish, Richard Horton


      PubDate: 2017-07-24T04:30:16Z
      DOI: 10.1016/s0140-6736(17)31756-7
       
  • Health inequality across prefectures in Japan
    • Authors: Churnrurtai Kanchanachitra; Viroj Tangcharoensathien
      Abstract: Publication date: Available online 19 July 2017
      Source:The Lancet
      Author(s): Churnrurtai Kanchanachitra, Viroj Tangcharoensathien


      PubDate: 2017-07-24T04:30:16Z
      DOI: 10.1016/s0140-6736(17)31792-0
       
  • Bioresorbable scaffolds: in search of event-free dissolution
    • Authors: Raffaele Piccolo; Peter Jüni; Stephan Windecker
      Abstract: Publication date: Available online 18 July 2017
      Source:The Lancet
      Author(s): Raffaele Piccolo, Peter Jüni, Stephan Windecker


      PubDate: 2017-07-24T04:30:16Z
      DOI: 10.1016/s0140-6736(17)31871-8
       
  • 2-year outcomes with the Absorb bioresorbable scaffold for treatment of
           coronary artery disease: a systematic review and meta-analysis of seven
           randomised trials with an individual patient data substudy
    • Authors: Ziad A Ali; Patrick W Serruys; Takeshi Kimura; Runlin Gao; Stephen G Ellis; Dean J Kereiakes; Yoshinobu Onuma; Charles Simonton; Zhen Zhang; Gregg W Stone
      Abstract: Publication date: Available online 18 July 2017
      Source:The Lancet
      Author(s): Ziad A Ali, Patrick W Serruys, Takeshi Kimura, Runlin Gao, Stephen G Ellis, Dean J Kereiakes, Yoshinobu Onuma, Charles Simonton, Zhen Zhang, Gregg W Stone
      Background Bioresorbable vascular scaffolds (BVS) offer the potential to improve long-term outcomes of percutaneous coronary intervention after their complete bioresorption. Randomised trials have shown non-inferiority between BVS and metallic drug-eluting stents at 1 year in composite safety and effectiveness outcomes, although some increases in rates of target vessel-related myocardial infarction and device thrombosis were identified. Outcomes of BVS following the first year after implantation are unknown. We sought to ascertain whether BVS are as safe and effective as drug-eluting stents within 2 years after implantation and between 1 and 2 years. Methods We did a systematic review and meta-analysis of randomised trials in which patients were randomly assigned to everolimus-eluting Absorb BVS or metallic everolimus-eluting stents (EES) and followed up for at least 2 years. We searched MEDLINE, the Cochrane database, TCTMD, ClinicalTrials.gov, Clinical Trial Results, CardioSource, and abstracts and presentations from major cardiovascular meetings up to April 1, 2017, to identify relevant studies. The primary efficacy outcome measure was the device-oriented composite endpoint (cardiac mortality, target vessel-related myocardial infarction, or ischaemia-driven target lesion revascularisation) and the primary safety outcome measure was definite or probable device thrombosis. Individual patient data from the four ABSORB trials were used for landmark and subgroup analysis and multivariable modelling. Findings We identified seven randomised trials in which 5583 patients were randomly assigned to Absorb BVS (n=3261) or metallic EES (n=2322) and followed up for 2 years. BVS had higher 2-year relative risks of the device-oriented composite endpoint than did EES (9·4% [304 of 3217] vs 7·4% [169 of 2299]; relative risk [RR] 1·29 [95% CI 1·08–1·56], p=0·0059). These differences were driven by increased rates of target vessel-related myocardial infarction (5·8% [187 of 3218] vs 3·2% [74 of 2299]; RR 1·68 [95% CI 1·29–2·19], p=0·0003) and ischaemia-driven target lesion revascularisation (5·3% [169 of 3217] vs 3·9% [90 of 2300]; 1·40 [1·09–1·80], p=0·0090) with BVS, with non-significant differences in cardiac mortality. The cumulative 2-year incidence of device thrombosis was higher with BVS than with EES (2·3% [73 of 3187] vs 0·7% [16 of 2281]; RR 3·35 [95% CI 1·96–5·72], p<0·0001). Landmark analysis between 1 and 2 years also showed higher rates of the device-oriented composite endpoint (3·3% [69 of 2100] vs 1·9% [23 of 1193]; RR 1·64 [95% CI 1·03–2·61], p=0·0376) and device thrombosis (0·5% [11 of 2085] vs none [0 of 1183], p<0·0001) in BVS-treated patients than in EES-treated patients. Interpretation BVS was associated with increased rates of composite device-oriented adverse events and device thrombosis cumulatively at 2 years and between 1 and 2 years of follow-up compared with EES. Funding Abbott Vascular.

      PubDate: 2017-07-24T04:30:16Z
      DOI: 10.1016/s0140-6736(17)31470-8
       
  • Ending our shame: call for a fundamental reconsideration of Australian
           refugee policy
    • Authors: Elizabeth A Bennett; Louise Newman; Julian WK Burnside; Barri Phatarfod; Robert M Thomas; A Rob Moodie; Michael J Moore
      Abstract: Publication date: Available online 18 July 2017
      Source:The Lancet
      Author(s): Elizabeth A Bennett, Louise Newman, Julian WK Burnside, Barri Phatarfod, Robert M Thomas, A Rob Moodie, Michael J Moore


      PubDate: 2017-07-24T04:30:16Z
      DOI: 10.1016/s0140-6736(17)31914-1
       
  • Treatment of Duchenne muscular dystrophy: first small steps
    • Authors: Claire L Wood; Tim Cheetham
      Abstract: Publication date: Available online 17 July 2017
      Source:The Lancet
      Author(s): Claire L Wood, Tim Cheetham


      PubDate: 2017-07-24T04:30:16Z
      DOI: 10.1016/s0140-6736(17)31669-0
       
  • Public genomes: the future of the NHS'
    • Authors: Lancet
      Abstract: Publication date: 15–21 July 2017
      Source:The Lancet, Volume 390, Issue 10091
      Author(s): The Lancet


      PubDate: 2017-07-24T04:30:16Z
       
  • Canada’s feminist foreign aid agenda
    • Authors: Lancet
      Abstract: Publication date: 15–21 July 2017
      Source:The Lancet, Volume 390, Issue 10091
      Author(s): The Lancet


      PubDate: 2017-07-24T04:30:16Z
       
  • Curbing the rise in gonococcal AMR
    • Authors: Lancet
      Abstract: Publication date: 15–21 July 2017
      Source:The Lancet, Volume 390, Issue 10091
      Author(s): The Lancet


      PubDate: 2017-07-24T04:30:16Z
       
  • Interleukin 23 inhibitors for psoriasis: not just another number
    • Authors: Bachelez
      Abstract: Publication date: 15–21 July 2017
      Source:The Lancet, Volume 390, Issue 10091
      Author(s): Hervé Bachelez


      PubDate: 2017-07-24T04:30:16Z
       
  • New hepatitis C antiviral treatments eliminate the virus
    • Authors: Joseph S Doyle; Alexander J Thompson; Peter Higgs; Mark Stoove; Paul M Dietze; Margaret E Hellard
      Abstract: Publication date: Available online 7 July 2017
      Source:The Lancet
      Author(s): Joseph S Doyle, Alexander J Thompson, Peter Higgs, Mark Stoove, Paul M Dietze, Margaret E Hellard


      PubDate: 2017-07-14T04:45:48Z
      DOI: 10.1016/s0140-6736(17)31817-2
       
  • Open letter to the UN's new health chief from “Alternative Nobel
           Prize” laureates
    • Authors: Sima Samar; Gino Strada; Monika Hauser; Ran Goldstein; Denis Mukwege
      Abstract: Publication date: Available online 7 July 2017
      Source:The Lancet
      Author(s): Sima Samar, Gino Strada, Monika Hauser, Ran Goldstein, Denis Mukwege


      PubDate: 2017-07-14T04:45:48Z
      DOI: 10.1016/s0140-6736(17)31818-4
       
 
 
JournalTOCs
School of Mathematical and Computer Sciences
Heriot-Watt University
Edinburgh, EH14 4AS, UK
Email: journaltocs@hw.ac.uk
Tel: +00 44 (0)131 4513762
Fax: +00 44 (0)131 4513327
 
Home (Search)
Subjects A-Z
Publishers A-Z
Customise
APIs
Your IP address: 54.162.164.247
 
About JournalTOCs
API
Help
News (blog, publications)
JournalTOCs on Twitter   JournalTOCs on Facebook

JournalTOCs © 2009-2016